Diaz-Gonzalez A, Hernandez-Guerra M, Perez-Medrano I, Sapena V, et al. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predni(so)lone administration. Hepatology 2023 Jan 3. doi: 10.1097/HEP.0000000000000018.
PMID: 36626622